IMC helps bring drugs to market sooner. Med-ic® is the only Smart blister ever submitted with a FDA priority review resulting in a blockbuster drug approval (Orlissa). med-ic.com
Leading the Way in Adherence Insights: The Unrivaled Success of Information Mediary Corp Since its inception over two decades ago, Information Mediary Corp (IMC) has meticulously built a multi-disciplinary team with a singular focus: to bridge diverse industries and deliver the most advanced smart blister solution to the market. The driving force behind our journey has always been to be the absolute best in this field, and the result has been beyond our expectations. To our own surprise, and the surprise of many, the Med-ic smart blister has emerged as the ONLY viable smart blister solution that is widely used in large clinical trials. This unprecedented success has solidified our position as trailblazers in the industry, showcasing the efficacy, reliability, and unparalleled performance of our innovative solutions. As we reflect on this remarkable milestone, we remain steadfast in our commitment to pushing the boundaries of pharmaceutical research and delivering solutions that stand as the pinnacle of excellence. The unwavering dedication of our multi-disciplinary team continues to drive the success of the Med-ic smart blister, reinforcing our status as the unrivaled leader in pioneering smart blister technology. As we celebrate this achievement, we extend our gratitude to our partners, clients, and collaborators who have placed their trust in us. Together, we have helped change the landscape of pharmaceutical research, setting new standards of excellence and ushering in a new era of innovation. Looking ahead, we remain resolute in our mission to continue shaping the future of patient care, pioneering groundbreaking solutions, and cementing Information Mediary Corp as the unrivaled leader in the pharmaceutical research domain. With the Med-ic smart blister, we have set a new benchmark for excellence, and we are committed to surpassing it with each new iteration. Thank you for joining us on this extraordinary journey, and we look forward to shaping the future of pharmaceutical research together. The best is yet to come. #medicationadherence #clinicaltrials #clinicalresearch #smartpackaging #remotetrials #mems #ecap #certiscan #cmoinsights
